Next, we established a prognostic model including five genes (ANXA1, DOK7, FKBP10, MAP1B and SPOCD1) to obtain a metrics that can forecast the clinical survival rate of BLCA patients accurately and effectively. This evidence concerns the gene ANXA1 and bladder transitional cell carcinoma.